About this document
Oclacitinib for Canine Dermatitis Treatment by ScribdTranslations is a document available to read on EtoBox.
Oclacivet (oclacitinib maleate) is an FDA-approved JAK inhibitor for controlling itching associated with allergic dermatitis in dogs over one year old. It works by inhibiting JAK1 and JAK3 cytokines, showing a bioavailability of 89% and peak plasma concentration within an hour after oral administration. Common adverse effects include gastrointestinal issues, and it is contraindicated in dogs under 12 months, those with severe infections, or pregnant/lactating bitches.
- Author
- ScribdTranslations
- Language
- EN